News and Updates

Leading researchers from around the world will gather for the annual meeting of the European Association for the Study of Diabetes (EASD).

Breakthrough T1D mourns the passing of Susan Solomon

Glucagon. It’s a word familiar to people with T1D, yet one most hope to avoid discussing. But what is glucagon and what is its role in the management of T1D?

The FDA authorized the Insulet Omnipod 5, the world’s first tubeless, wearable system, for children 2+, using an algorithm that began by Breakthrough T1D funding.

Breakthrough T1D-funded researchers in Colorado and Germany found no link between COVID-19 and type 1 diabetes in children and adolescents ages 1-18.

Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA partnered up to tackle it—and the results were just published.

Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!

Stem cells have the potential to lead to treatments for type 1 diabetes, but it has taken Breakthrough T1D more than 20 years to get to this point.

At the ADA’s Scientific Sessions, Breakthrough T1D scientists presented on some of the most important topics, all with the same goal: Ending type 1 diabetes.

From June 3-7, diabetes researchers around the world will gather—in person!—at the American Diabetes Association’s 82nd Scientific Sessions. #JDRFxADA